decitabine

Details

Generic Name:

decitabine

Project Status:

Not filed

Therapeutic Area:

Myelodysplastic Syndromes

Manufacturer:

Pharmascience Inc.

Brand Name:

Demylocan

Project Line:

Reimbursement Review

Project Number:

NS0001-000

Submission Type:

Non Submission

Fee Schedule:

N/A

Indications:

Myelodysplastic Syndromes

Sponsor:

Recommendation Type:

Unable to recommend reimbursement

CADTH is unable to recommend reimbursement of the relevant product because a submission to CADTH was not filed by the manufacturer.

Last Updated : May 29, 2019